XML 8 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 178,357 $ 193,513
Accounts receivable 14,139 14,454
Receivables from collaboration arrangement 61,871 69,621
Inventory 37,437 40,737
Prepaid expenses 16,551 21,630
Other current assets 2,987 4,264
Total current assets 311,342 344,219
Property and equipment, net 324 483
Equity method investments 151,888 116,546
Equity and long-term investments 476,549 444,432
Capitalized fees paid, net 80,328 83,784
Right-of-use assets 2,269 2,536
Goodwill 17,905 17,905
Intangible assets 223,895 230,335
Other assets 3,112 3,267
Total assets 1,267,612 1,243,507
Current liabilities:    
Accounts payable 890 6,717
Accrued personnel-related expenses 3,422 7,020
Accrued interest payable 833 3,422
Deferred revenue 987 1,277
Other accrued liabilities 23,747 19,698
Total current liabilities 29,879 38,134
Long-term debt, net of discount and issuance costs 446,759 446,234
Other long-term liabilities 71,686 71,870
Deferred tax liabilities, net 3,807 563
Income tax payable, long-term 11,800 11,751
Commitments and contingencies (Note 12)
Stockholders' equity:    
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding 0 0
Common stock: $0.01 par value, 200,000 shares authorized, 62,797 and 63,307 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 628 633
Treasury stock: at cost, 32,005 shares as of March 31, 2024 and December 31, 2023 (393,829) (393,829)
Additional paid-in capital 1,085,539 1,093,340
Retained earnings (accumulated deficit) 11,343 (25,189)
Total stockholders' equity 703,681 674,955
Total liabilities and stockholders' equity $ 1,267,612 $ 1,243,507